CollPlant Biotechnologies (CLGN)
(Delayed Data from NSDQ)
$4.97 USD
-0.03 (-0.60%)
Updated Jun 28, 2024 12:53 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
CollPlant Biotechnologies Ltd. Sponsored ADR [CLGN]
Reports for Purchase
Showing records 41 - 51 ( 51 total )
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY- Reports the Quarter as We Move Closer to Catalysts
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
We Expect Major Milestones in 2020 in Spite of COVID-19; Higher $11PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Awaiting Additional Partnership Announcements; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Pure Collagen from Tobacco, A Healthier Alternative
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Advances in 3D Bioprinting and Dermal Filler; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Termination of coverage
Provider: Edison Investment Research Limited
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Farming a Better Human Collagen; Initiate With Buy and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Enters into licensing and commercialisation agreement
Provider: Edison Investment Research Limited
Analyst: JACOBS M